JAK2V617F

Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy
Yasutaka Fukuda, Marito Araki, Kouji Yamamoto, Soji Morishita, Tadaaki Inano, Kyohei Misawa, Tomonori Ochiai, Yoko Edahiro, Misa Imai, Hajime Yasuda, Akihiko Gotoh, Akimichi Ohsaka, Norio Komatsu

Haematologica Apr 2019, haematol.2018.208876; DOI: 10.3324/haematol.2018.208876
Clinical and biological characterization of patients with low (0.1–2%) JAK2V617F allele burden at diagnosis
Eric Lippert, Olivier Mansier, Marina Migeon, Barbara Denys, Asa Nilsson, Carolina Rosmond, Laurence Lodé, Valérie Ugo, Axelle Lascaux, Beatriz Bellosillo, Joaquin Martinez-Lopez, Dina Naguib, Nathalie Gachard, Nicolas Maroc, Sylvie Hermouet

Haematologica Jul 2014, 99 (7) e098-e101; DOI: 10.3324/haematol.2014.107656